Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.6560
+0.0218 (3.44%)
At close: Apr 1, 2025, 4:00 PM
0.6418
-0.0142 (-2.16%)
After-hours: Apr 1, 2025, 4:35 PM EDT

Adial Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
5.065.628.919.35.07
Upgrade
Research & Development
3.231.271.958.45.85
Upgrade
Operating Expenses
8.286.8910.8617.6910.93
Upgrade
Operating Income
-8.28-6.89-10.86-17.69-10.93
Upgrade
Interest & Investment Income
0.180.070.060.010.03
Upgrade
Earnings From Equity Investments
-0.55-0.19---
Upgrade
Other Non Operating Income (Expenses)
-4.540.01-0.020
Upgrade
EBT Excluding Unusual Items
-13.2-7-10.8-17.67-10.89
Upgrade
Merger & Restructuring Charges
----0.05-
Upgrade
Asset Writedown
----1.55-
Upgrade
Other Unusual Items
----0.25-
Upgrade
Pretax Income
-13.2-7-10.8-19.52-10.89
Upgrade
Income Tax Expense
----0.09-
Upgrade
Earnings From Continuing Operations
-13.2-7-10.8-19.42-10.89
Upgrade
Earnings From Discontinued Operations
-1.88-1.94--
Upgrade
Net Income
-13.2-5.12-12.73-19.42-10.89
Upgrade
Net Income to Common
-13.2-5.12-12.73-19.42-10.89
Upgrade
Shares Outstanding (Basic)
51110
Upgrade
Shares Outstanding (Diluted)
51110
Upgrade
Shares Change (YoY)
240.54%42.25%34.69%49.15%26.50%
Upgrade
EPS (Basic)
-2.72-3.60-12.71-26.12-21.85
Upgrade
EPS (Diluted)
-2.72-3.60-12.71-26.12-21.85
Upgrade
Free Cash Flow
-6.92-6.81-11.19-12.01-7.63
Upgrade
Free Cash Flow Per Share
-1.43-4.78-11.17-16.16-15.31
Upgrade
EBITDA
-8.28-6.89-10.86-17.69-10.93
Upgrade
D&A For EBITDA
0000.010
Upgrade
EBIT
-8.28-6.89-10.86-17.69-10.93
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q